Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-17

FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved an original ANDA for fluphenazine decanoate, a long-acting injectable antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prolixin Decanoate (Fluphenazine decanoate)

Snippet

ORIG AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)